CERBAI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 18.446
EU - Europa 12.217
AS - Asia 6.809
SA - Sud America 963
AF - Africa 178
OC - Oceania 176
Continente sconosciuto - Info sul continente non disponibili 2
Totale 38.791
Nazione #
US - Stati Uniti d'America 18.281
RU - Federazione Russa 4.293
PL - Polonia 2.609
SG - Singapore 1.974
IT - Italia 1.522
HK - Hong Kong 1.486
CN - Cina 1.410
IE - Irlanda 1.054
BR - Brasile 819
SE - Svezia 811
KR - Corea 763
DE - Germania 464
FI - Finlandia 366
VN - Vietnam 318
UA - Ucraina 300
GB - Regno Unito 291
IN - India 256
FR - Francia 171
AU - Australia 170
JO - Giordania 134
TR - Turchia 127
ID - Indonesia 95
CA - Canada 93
CI - Costa d'Avorio 76
CH - Svizzera 63
AR - Argentina 62
JP - Giappone 57
BE - Belgio 54
NL - Olanda 54
MX - Messico 52
ES - Italia 51
BD - Bangladesh 39
ZA - Sudafrica 35
IQ - Iraq 31
AT - Austria 27
EC - Ecuador 26
LT - Lituania 21
SC - Seychelles 21
VE - Venezuela 18
GR - Grecia 14
MA - Marocco 13
PK - Pakistan 12
RO - Romania 12
CO - Colombia 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
PH - Filippine 9
PY - Paraguay 9
SA - Arabia Saudita 9
TW - Taiwan 9
CL - Cile 8
IL - Israele 8
AZ - Azerbaigian 7
KE - Kenya 7
TN - Tunisia 7
KZ - Kazakistan 6
TH - Thailandia 6
BJ - Benin 5
DZ - Algeria 5
IR - Iran 5
KW - Kuwait 5
NZ - Nuova Zelanda 5
PE - Perù 5
RS - Serbia 5
BO - Bolivia 4
MY - Malesia 4
NO - Norvegia 4
CR - Costa Rica 3
DK - Danimarca 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
NP - Nepal 3
PT - Portogallo 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
HU - Ungheria 2
LC - Santa Lucia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CG - Congo 1
IM - Isola di Man 1
Totale 38.779
Città #
Santa Clara 3.692
Warsaw 2.601
Fairfield 1.915
Ashburn 1.499
Singapore 1.267
Hong Kong 1.241
Chandler 1.091
Dublin 1.048
Woodbridge 927
Cambridge 788
Seattle 778
Seoul 756
Houston 696
Wilmington 634
Beijing 470
Jacksonville 426
Ann Arbor 412
Altamura 346
Lawrence 346
Florence 336
Hefei 290
Princeton 290
Buffalo 263
Dallas 253
Boston 224
Los Angeles 221
Boardman 199
Munich 183
Mumbai 179
Moscow 173
Melbourne 164
San Diego 125
Medford 123
New York 105
Izmir 96
Falls Church 94
Ho Chi Minh City 93
Shanghai 83
The Dalles 83
São Paulo 82
Paris 79
Milan 78
Abidjan 76
Kent 76
Turku 69
Jakarta 68
London 67
Norwalk 65
Dong Ket 62
Bern 61
Redondo Beach 57
Helsinki 56
Hanoi 55
Brussels 51
Tokyo 50
Rome 49
Clifton 48
Toronto 40
Chicago 38
San Jose 36
Council Bluffs 35
Dearborn 35
Frankfurt am Main 33
Hillsboro 30
Montreal 27
Phoenix 27
Andover 26
Columbus 26
Yubileyny 26
Johannesburg 21
Tianjin 21
Vienna 21
Brasília 20
Falkenstein 20
Guangzhou 20
Poplar 20
Rio de Janeiro 20
Belo Horizonte 19
Mexico City 19
Scandicci 19
Barcelona 18
Brooklyn 18
Amsterdam 17
Poggio A Caiano 17
Bengaluru 16
Chennai 16
Bologna 15
Redmond 15
Sesto Fiorentino 15
Lappeenranta 14
Orem 14
Siena 14
Manchester 13
Salvador 13
Atlanta 12
Auburn Hills 12
Guayaquil 11
Murcia 11
Münster 11
Tappahannock 11
Totale 26.541
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 424
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 374
Atrial Remodeling in Hypertrophic Cardiomyopathy 363
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 337
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes 327
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 312
Pharmacological perspectives in sarcopenia: A potential role for renin-angiotensin system blockers? 309
New isoform-selective HCN blockers 302
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 296
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 285
Growth Factor-Induced Mobilization of Cardiac Progenitor Cells Reduces the Risk of Arrhythmias, in a Rat Model of Chronic Myocardial Infarction 280
Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats 265
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 262
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy 258
Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes. 253
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 252
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 249
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 247
Mesoscopic optical imaging of whole mouse heart 245
The funny current in cardiac non-pacemaker cells: functional role and pharmacological modulation 242
Antiarrhythmic properties of naloxone: an electrophysiological study on sheep cardiac Purkinje fibers 241
Losartan ameliorates diabetic vascular hyper-reactivity to angiotensin II by reducing ROCK1 expression and activity 239
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 238
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 232
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy 224
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. 223
Design of muscle contraction assist devices by liquid crystalline elastomers 217
Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach 211
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 211
Design, synthesis and preliminary biological evaluation of new isoform-selective f-current blockers. 206
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 206
Angiotensin-II drives human satellite cells toward hypertrophy and myofibroblast trans-differentiation by two independent pathways 206
Cardiac effects of 3-iodothyronamine: A new aminergic system modulating cardiac function 203
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 203
Long term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. 200
Ethical-legal aspects of organoids and their use in research. Manage risks and legal constraints for the development of ethical research 195
Arrhythmia susceptibility in a rat model of acute atrial dilation 194
Modulation of Cardiac Ionic Homeostasis by 3-Iodothyronamine. 193
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 193
Real-time optical manipulation of cardiac conduction in intact hearts 192
Electrophysiological Characterization of Isolated Human Atrial Myocytes Exposed to Tegaserod 190
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 189
Action potential propagation in transverse-axial tubular system is impaired in heart failure 187
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 187
Prenatal exposure to carbon monoxide delays postnatal cardiac maturation. 183
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 182
Ranolazine normalizes action potential duration in angiotensin II exposed HL-1 cells: role of late sodium current 178
The transverse-axial tubular system of cardiomyocytes. 177
Chronic Atrial Fibrillation Alters the Functional Properties of Ifin the Human Atrium 175
Prenatal exposure to carbon monoxide affects postnatal cellular electrophysiological maturation of the rat heart: a potential substrate for arrhythmogenesis in infancy 174
A molecular basis for HCN channel over-expression. 174
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 173
Atrial natriuretic peptide modulates the hyperpolarization-activated current (I(f)) in human atrial myocytes. 171
SELECTIVITY OF DIFFERENT CALCIUM ANTAGONISTS ON T- AND L-TYPE CALCIUM CURRENTS IN GUINEA-PIG VENTRICULAR MYOCYTES. 170
AUTONOMIC NERVOUS SYSTEM AND ARRHYTHMOGENESIS 170
NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle. 169
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling 169
The effect of losartan treatment on the response of diabetic cardiomyocytes to ATP depletion 167
If channels as a therapeutic target in heart disease 166
ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. 165
CHARACTERISTICS OF L-TYPE CALCIUM CHANNEL BLOCKADE BY LACIDIPINE IN GUINEA-PIG VENTRICULAR MYOCYTES 164
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 164
Molecular and functional development of cardiomyocytes differentiated from human embryonic stem cells. 162
Impact of detubulation on force and kinetics of cardiac muscle contraction 162
Expression of the hyperpolarization-activated current, I(f), in cultured adult rat ventricular cardiomyocytes and its modulation by hypertrophic factors 162
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 161
Functional expression and subcellular localization of f-channels in native human and HESC-derived cardiomyocytes 160
R4496C RyR2 mutation impairs atrial and ventricular contractility 160
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 159
Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium. 159
Enhanced ROS production by NADPH oxidase is correlated to changes in antioxidant enzyme activity in human heart failure 159
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues 158
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 157
Whole heart cytoarchitecture at micron-scale resolution 156
Molecular basis of funny current (If) in normal and failing human heart. 156
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 156
Acute appendicitis in a patient immunised with COVID-19 vaccine: a case report with morphological analysis 156
Optical clearing in cardiac imaging: A comparative study 156
Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: From molecular mechanisms to therapeutic implications 155
Microled Illumination Towards Liquid Crystalline Elastomers Based Cardiac Contraction Assistance 155
5-HT2 receptors enable cardiac differentiation of mouse embryonic stem cells 152
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 152
New phenylalkylamines as isoform selective HCN-Channels blockers 150
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 150
Functional remodeling in post-myocardial infarcted rats: focus on beta-adrenoceptor subtypes. 147
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 147
Photoresponsive Polymer-Based Biomimetic Contractile Units as Building Block for Artificial Muscles 146
Cellular electrophysiological basis for oxygen radical-induced arrhythmias. A patch-clamp study in guinea pig ventricular myocytes. 145
Endothelin-1 promotes cellular electrophysiological remodeling by affecting IKr expression in cardiac HL-1 cells. 145
Updates on HCN channels in the heart: Function, Dysfunction and pharmacology 145
NADPH oxidase is related with lipid peroxidation and redox-sensitive kinase activation in human failing hearts 145
Novel blockers of hyperpolarization-activated current with isoform selectivity in recombinant cells and native tissue. 145
Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome 142
The HCN channel as a pharmacological target: Why, where, and how to block it 142
Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh. 141
Response to Letter Regarding Article, "Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy" 141
Electrophysiological evaluation of novel blockers of If current. 140
n-3 polyunsaturated fatty acid supplementation reduces asymmetric dimethylarginine and arachidonate accumulation in spontaneously hypertensive rats 139
Electrophysiological effects mediated by the stimulation of cardiac β2-adrenoceptors with tulobuterol 139
Do amniotic fluid-derived stem cells differentiate into neurons in vitro? 139
Totale 19.694
Categoria #
all - tutte 110.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.048 0 0 0 0 0 461 192 235 263 524 168 205
2021/20222.064 55 184 171 82 93 106 93 129 122 94 359 576
2022/20234.827 476 899 183 308 426 893 577 245 526 43 135 116
2023/20241.676 96 224 306 87 104 194 84 314 27 58 90 92
2024/202511.973 441 1.364 840 1.716 3.209 1.522 216 838 629 311 461 426
2025/20266.976 1.326 1.910 1.048 1.130 1.502 60 0 0 0 0 0 0
Totale 39.100